Trial intelligence / Profile preview

Randomized controlled trial of lidocaine patch for lower limb amputation pain

2016-000864-41Phase 2Completed

Sponsor
CHU Brugmann
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of lidocaine in phantom limb pain (PLP), post-amputation pain (PAP) and scar hyperalgesia (2 arms), sponsored by CHU Brugmann. Primary endpoint: Reported overall daily pain intensity. Started Mar 2016; status: completed.

02

Drugs

lidocaine
03

Conditions

phantom limb pain (PLP)post-amputation pain (PAP)scar hyperalgesia

Beyond the preview

Go deeper on 2016-000864-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000864-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call